SenesTech (SNES)
Evolve and ContraPest rodent fertility-control baits.
Something off on this page? Send us feedback.
Sells Evolve and ContraPest rodent-fertility baits through online, professional, distributor, and municipal channels. Revenue is product sales, with continued consumption needed because the products limit fertility temporarily rather than permanently sterilizing rodents.
Formulates and sells rodent-fertility-control products that reduce reproduction in rats and mice. Evolve Rat and Evolve Mouse are cottonseed-oil soft baits, while ContraPest is a liquid bait for Norway and roof rats; delivery systems include bait stations, starter kits, refills, and a hanging dispenser.
Manufactures at its Arizona facility and sells through direct e-commerce, Amazon, other retailer sites, distributors, pest-management professionals, agricultural and commercial accounts, municipalities, and international distributors. Evolve is the portfolio’s revenue center, and subscriptions support recurring replenishment.
Product availability depends on federal and state authorizations: Evolve uses the minimum-risk pesticide framework and state-by-state approvals, whereas ContraPest requires registrations and label compliance. Production-scale manufacturing is concentrated at one Arizona facility.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $5.1M · Total debt $2.6M · Total assets $9.4M · Shareholders' equity $6.1M
- Revenue
- $770.0K
- Operating income
- −$1.9M
- Net income
- −$1.8M
No dividends on record.
| Institutions | 9.06% | 491.6K shares | |
|---|---|---|---|
| 17 holders · as of Jun 30, 2026 | |||
| Insiders | 0.17% | 9.0K shares | |
| 1 holder · as of Sep 15, 2026 | |||
| Strategic holders | 19.90% | 1.08M shares | |
| 1 holder · as of Aug 10, 2026 | |||
| Other | 70.87% | 3.84M shares | |
| remainder | |||
5.42M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Glenbrook Capital ManagementStrategic10 percent owner | 19.90% | 1.08M | filed Aug 10, 2026 |
Sabby Management, LLCInstitution | 2.61% | 141,756 | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 1.52% | 82,616 | as of Jun 30, 2026 |
Citadel Advisors LLCInstitution | 0.86% | 46,671 | as of Jun 30, 2026 |
Geode Capital Management, LLCInstitution | 0.82% | 44,339 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 14, 2026 | Michael Edell | director, officer: Chief Executive Officer | +1,000 | $0.8400 |
| Sep 9, 2026 | Michael Edell | director, officer: Chief Executive Officer | +2,000 | $0.8700 |
| Aug 14, 2026 | Michael Edell | director, officer: Chief Executive Officer | +1,000 | $1.21 |
| Aug 7, 2026 | Glenbrook Capital Management | 10 percent owner | +6,490 | $1.30 |
| Aug 6, 2026 | Glenbrook Capital Management | 10 percent owner | +15,000 | $1.30 |
- Scotts Miracle-Gro
Consumer rodent bait, station, trap, and repellent substitute.
- Neogen
Direct consumer and farm rodenticide, trap, and bait-station substitute.
- Ecolab
Commercial IPM service substitute with bait stations, traps, and monitoring.
- Rollins
Recurring residential and commercial rodent-control service substitute.
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| SenesTech | $0.7810 | +0.12% | $4.3M | — | — | 1.8 | +23.2% |
| Scotts Miracle-Gro | $52.84 | +0.32% | $2.99B | 44.7 | 11.6 | 0.9 | −1.3% |
| Neogen | $13.98 | −0.04% | $2.97B | — | 47.7 | 3.4 | −0.1% |
| Ecolab | $276.22 | +0.01% | $75.98B | 36.2 | 32.0 | 4.5 | +9.7% |
| Rollins | $32.86 | −0.06% | $15.57B | 29.4 | 27.4 | 4.0 | +7.9% |
| Median | 36.2 | 29.7 | 3.7 | +3.9% |